KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Cash from Operations (2020 - 2026)

AbCellera Biologics filings provide 7 years of Cash from Operations readings, the most recent being 33523000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 190.14% to 33523000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 153264000.0 through Mar 2026, down 95.48% year-over-year, with the annual reading at 131295000.0 for FY2025, 20.95% down from the prior year.
  • Cash from Operations hit 33523000.0 in Q1 2026 for AbCellera Biologics, up from 34743000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 273015000.0 in Q2 2022 and bottomed at 126786000.0 in Q3 2022.
  • Average Cash from Operations over 5 years is 2346529.41, with a median of 28882000.0 recorded in 2024.
  • The largest annual shift saw Cash from Operations soared 284.97% in 2022 before it tumbled 27147.17% in 2024.
  • AbCellera Biologics' Cash from Operations stood at 30912000.0 in 2022, then tumbled by 163.44% to 19611000.0 in 2023, then skyrocketed by 59.21% to 8000000.0 in 2024, then tumbled by 334.29% to 34743000.0 in 2025, then rose by 3.51% to 33523000.0 in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Cash from Operations are 33523000.0 (Q1 2026), 34743000.0 (Q4 2025), and 52594000.0 (Q3 2025).